Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases

Detalhes bibliográficos
Ano de defesa: 2020
Autor(a) principal: Oliveira, Artur Ramon Tomé
Orientador(a): Mattos, Marcos Carlos de
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Não Informado pela instituição
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://www.repositorio.ufc.br/handle/riufc/55888
Resumo: The apremilast, marketed as OTZELA®, is a oral drug, used in psoriases and psoriatic arthritis psoriatic, acting as a anti-inflammatory. Is a recent drug, which was approved for FDA (Food Drug Administration) in 2014. The drug referred have a only stereogenic center and is commercialized in enantiomerically pure form, since what the (S)-enantiomer is more active which the (R)-enantiomer. In this work we describe the preliminary results referred the chemoenzymatic synthesis of apremilast intermediates in lipases presence, being the key-step, the obtaining of amine (S-2)-1-(3-ethoxy-4-methoxyphenyl)-1-methylsulfonyl-2-ethylamine, (S)-36. That intermediate can be obtained through kinetic resolution of amine rac-36, via carbamation reaction using lipases. The amine rac-36 was prepared, as 70% yield, via two sequential steps one-pot, which consisted in 3-ethoxy-4-methoxybenzonitrile, 38, reaction with (methylsulfonyl)methanide (formed carbanion among the dimethylsulfone and n-butyl-lithium), with obtaining of the enamine 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine 39, treatment followed with NaBH4, in glacial acetic acid. The 1-(3-ethoxy-4-methoxyfenyl)-2-(mehtylsulfonyl)ethyl)alyl carbamate, rac-49, was prepared starting of amine rac-34 via carbamation reaction with allyl chloroformate, in triethylamine presence, 89% yield. Both, the amine rac-34 and the carbamate rac-49 corresponding was analyzed by CLAE, using a chiral column, and ideal conditions for the enantiomers separation. The first approach to be studied was the lipase behavior in several solvents in 40 ºC for 72 h for kinetic resolution of amine rac-36, via carbamation reaction. Highlighted the solvents which show low value of dielectric constant: THF, TBME, hexane, cyclohexane and toluene, since which the best result was obtained in hexane, in CAL-B presence, as 14% conversion and >200 enantioselectivity (E). Also of CAL-B, the Candida rugosa lipase and CAL-A are promising in kinetic resolution of rac-36. In parallel, the commercial anhydride 3- nitrophthalic anhydride 50, was effectively transforming in 3-aminophthalic, 51, qualitative yield. The latter was subjected to an acetylation reaction to obtain 3-acetylaminophthalic anhydride 37, one of apremilast's intermediates, but with a yield of only 25%.
id UFC-7_0beee59f6c6ef7c9535b959bea9d0fed
oai_identifier_str oai:repositorio.ufc.br:riufc/55888
network_acronym_str UFC-7
network_name_str Repositório Institucional da Universidade Federal do Ceará (UFC)
repository_id_str
spelling Oliveira, Artur Ramon ToméSilva, Marcos Reinaldo daMattos, Marcos Carlos de2020-12-31T15:55:25Z2020-12-31T15:55:25Z2020OLIVEIRA, Artur Ramon Tomé. Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases. 2020. 82 f. Dissertação (Mestrado em Química) - Centro de Ciências, Universidade Federal do Ceará, Fortaleza, 2020.http://www.repositorio.ufc.br/handle/riufc/55888The apremilast, marketed as OTZELA®, is a oral drug, used in psoriases and psoriatic arthritis psoriatic, acting as a anti-inflammatory. Is a recent drug, which was approved for FDA (Food Drug Administration) in 2014. The drug referred have a only stereogenic center and is commercialized in enantiomerically pure form, since what the (S)-enantiomer is more active which the (R)-enantiomer. In this work we describe the preliminary results referred the chemoenzymatic synthesis of apremilast intermediates in lipases presence, being the key-step, the obtaining of amine (S-2)-1-(3-ethoxy-4-methoxyphenyl)-1-methylsulfonyl-2-ethylamine, (S)-36. That intermediate can be obtained through kinetic resolution of amine rac-36, via carbamation reaction using lipases. The amine rac-36 was prepared, as 70% yield, via two sequential steps one-pot, which consisted in 3-ethoxy-4-methoxybenzonitrile, 38, reaction with (methylsulfonyl)methanide (formed carbanion among the dimethylsulfone and n-butyl-lithium), with obtaining of the enamine 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine 39, treatment followed with NaBH4, in glacial acetic acid. The 1-(3-ethoxy-4-methoxyfenyl)-2-(mehtylsulfonyl)ethyl)alyl carbamate, rac-49, was prepared starting of amine rac-34 via carbamation reaction with allyl chloroformate, in triethylamine presence, 89% yield. Both, the amine rac-34 and the carbamate rac-49 corresponding was analyzed by CLAE, using a chiral column, and ideal conditions for the enantiomers separation. The first approach to be studied was the lipase behavior in several solvents in 40 ºC for 72 h for kinetic resolution of amine rac-36, via carbamation reaction. Highlighted the solvents which show low value of dielectric constant: THF, TBME, hexane, cyclohexane and toluene, since which the best result was obtained in hexane, in CAL-B presence, as 14% conversion and >200 enantioselectivity (E). Also of CAL-B, the Candida rugosa lipase and CAL-A are promising in kinetic resolution of rac-36. In parallel, the commercial anhydride 3- nitrophthalic anhydride 50, was effectively transforming in 3-aminophthalic, 51, qualitative yield. The latter was subjected to an acetylation reaction to obtain 3-acetylaminophthalic anhydride 37, one of apremilast's intermediates, but with a yield of only 25%.O apremilast, comercializado como OTZELA®, é um fármaco oral, utilizado no tratamento da psoríase e da artrite psoriática, atuando como um anti-inflamatório. É um fármaco recente, que foi aprovado pela FDA (Food Drug Administration) em 2014. O referido fármaco possui apenas um centro estereogênico e é comercializado na forma enantiomericamente pura, já que o (S)-enantiômero é mais ativo que o (R)-enantiômero. Neste trabalho descrevemos os resultados preliminares referentes à síntese quimioenzimática de intermediários do apremilast na presença de lipases, sendo a etapa chave, a obtenção da amina (S-2)-1-(3-etoxi-4-metoxifenil)-1-metilssulfonil-2-etilamina, (S)-36. Esse intermediário pode ser obtido através da resolução cinética da amina rac-36, via reação de carbamatação, catalisada por lipases. A amina rac-36 foi preparada, com 70% de rendimento, via duas etapas sequenciais one-pot, que consistiu na reação da 3-etoxi-4-metoxibenzonitrila 38 com o (metilssulfonil)metanídeo (carbânion formado entre a dimetilssulfona e n-butil-lítio), com a obtenção da enamina 1-(3-etoxi-4-metoxifenil)-2-(metilssulfonil)etenamina 39, seguido de tratamento com NaBH4, em ácido acético glacial. O carbamato de 1-(3-etoxi-4-metoxifenil)-2-(metilssulfonil)etil)alila rac-49 foi preparado a partir da amina rac-34 via reação de carbamatação com cloroformato de alila, na presença de trietilamina, com rendimento de 89%. Ambos, a amina rac-34 e o correspondente carbamato rac-49 foram analisados por CLAE, utilizando coluna quiral, e condições adequadas para a separação de seus correspondentes enantiômeros. A primeira abordagem a ser estudada foi o comportamento de lipases em diferentes solventes a 40 ºC por 72 h na resolução cinética da amina rac-36, via reação de carbamatação. Destacaram-se os solventes que apresentaram baixos valores de constante dielétrica: THF, TBME, hexano, cicloexano e tolueno, sendo que o melhor resultado foi obtido em hexano, na presença de CAL-B, com conversão de 14% e enantiosseletividade (E) >200. Além da CAL-B, a lipase de Candida rugosa e CAL-A mostram-se promissoras na resolução cinética de rac-36. Em paralelo, o anidrido comercial 3-nitroftálico 50 foi eficientemente transformado no anidrido-3-aminoftálico 51, em rendimento quantitativo. Este último, foi submetido a uma reação de acetilação para a obtenção do anidrido 3-acetilaminoftálico 37, um dos intermediários do apremilast, porém com rendimento de apenas 25%.CarbamataçãoLipasesApremilastResolução cinética enzimáticaSíntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipasesChemioenzymatic synthesis of apremilast via carbamatation intermediates, using lipasesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisporreponame:Repositório Institucional da Universidade Federal do Ceará (UFC)instname:Universidade Federal do Ceará (UFC)instacron:UFCinfo:eu-repo/semantics/openAccessLICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://repositorio.ufc.br/bitstream/riufc/55888/4/license.txt8a4605be74aa9ea9d79846c1fba20a33MD54ORIGINAL2020_dis_artoliveira.pdf2020_dis_artoliveira.pdfapplication/pdf2505180http://repositorio.ufc.br/bitstream/riufc/55888/3/2020_dis_artoliveira.pdfbe274a18cb8508ec24ce528e73b96166MD53riufc/558882020-12-31 12:55:25.544oai:repositorio.ufc.br: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Repositório InstitucionalPUBhttp://www.repositorio.ufc.br/ri-oai/requestbu@ufc.br || repositorio@ufc.bropendoar:2020-12-31T15:55:25Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)false
dc.title.pt_BR.fl_str_mv Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases
dc.title.en.pt_BR.fl_str_mv Chemioenzymatic synthesis of apremilast via carbamatation intermediates, using lipases
title Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases
spellingShingle Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases
Oliveira, Artur Ramon Tomé
Carbamatação
Lipases
Apremilast
Resolução cinética enzimática
title_short Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases
title_full Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases
title_fullStr Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases
title_full_unstemmed Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases
title_sort Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases
author Oliveira, Artur Ramon Tomé
author_facet Oliveira, Artur Ramon Tomé
author_role author
dc.contributor.co-advisor.none.fl_str_mv Silva, Marcos Reinaldo da
dc.contributor.author.fl_str_mv Oliveira, Artur Ramon Tomé
dc.contributor.advisor1.fl_str_mv Mattos, Marcos Carlos de
contributor_str_mv Mattos, Marcos Carlos de
dc.subject.por.fl_str_mv Carbamatação
Lipases
Apremilast
Resolução cinética enzimática
topic Carbamatação
Lipases
Apremilast
Resolução cinética enzimática
description The apremilast, marketed as OTZELA®, is a oral drug, used in psoriases and psoriatic arthritis psoriatic, acting as a anti-inflammatory. Is a recent drug, which was approved for FDA (Food Drug Administration) in 2014. The drug referred have a only stereogenic center and is commercialized in enantiomerically pure form, since what the (S)-enantiomer is more active which the (R)-enantiomer. In this work we describe the preliminary results referred the chemoenzymatic synthesis of apremilast intermediates in lipases presence, being the key-step, the obtaining of amine (S-2)-1-(3-ethoxy-4-methoxyphenyl)-1-methylsulfonyl-2-ethylamine, (S)-36. That intermediate can be obtained through kinetic resolution of amine rac-36, via carbamation reaction using lipases. The amine rac-36 was prepared, as 70% yield, via two sequential steps one-pot, which consisted in 3-ethoxy-4-methoxybenzonitrile, 38, reaction with (methylsulfonyl)methanide (formed carbanion among the dimethylsulfone and n-butyl-lithium), with obtaining of the enamine 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine 39, treatment followed with NaBH4, in glacial acetic acid. The 1-(3-ethoxy-4-methoxyfenyl)-2-(mehtylsulfonyl)ethyl)alyl carbamate, rac-49, was prepared starting of amine rac-34 via carbamation reaction with allyl chloroformate, in triethylamine presence, 89% yield. Both, the amine rac-34 and the carbamate rac-49 corresponding was analyzed by CLAE, using a chiral column, and ideal conditions for the enantiomers separation. The first approach to be studied was the lipase behavior in several solvents in 40 ºC for 72 h for kinetic resolution of amine rac-36, via carbamation reaction. Highlighted the solvents which show low value of dielectric constant: THF, TBME, hexane, cyclohexane and toluene, since which the best result was obtained in hexane, in CAL-B presence, as 14% conversion and >200 enantioselectivity (E). Also of CAL-B, the Candida rugosa lipase and CAL-A are promising in kinetic resolution of rac-36. In parallel, the commercial anhydride 3- nitrophthalic anhydride 50, was effectively transforming in 3-aminophthalic, 51, qualitative yield. The latter was subjected to an acetylation reaction to obtain 3-acetylaminophthalic anhydride 37, one of apremilast's intermediates, but with a yield of only 25%.
publishDate 2020
dc.date.accessioned.fl_str_mv 2020-12-31T15:55:25Z
dc.date.available.fl_str_mv 2020-12-31T15:55:25Z
dc.date.issued.fl_str_mv 2020
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv OLIVEIRA, Artur Ramon Tomé. Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases. 2020. 82 f. Dissertação (Mestrado em Química) - Centro de Ciências, Universidade Federal do Ceará, Fortaleza, 2020.
dc.identifier.uri.fl_str_mv http://www.repositorio.ufc.br/handle/riufc/55888
identifier_str_mv OLIVEIRA, Artur Ramon Tomé. Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases. 2020. 82 f. Dissertação (Mestrado em Química) - Centro de Ciências, Universidade Federal do Ceará, Fortaleza, 2020.
url http://www.repositorio.ufc.br/handle/riufc/55888
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal do Ceará (UFC)
instname:Universidade Federal do Ceará (UFC)
instacron:UFC
instname_str Universidade Federal do Ceará (UFC)
instacron_str UFC
institution UFC
reponame_str Repositório Institucional da Universidade Federal do Ceará (UFC)
collection Repositório Institucional da Universidade Federal do Ceará (UFC)
bitstream.url.fl_str_mv http://repositorio.ufc.br/bitstream/riufc/55888/4/license.txt
http://repositorio.ufc.br/bitstream/riufc/55888/3/2020_dis_artoliveira.pdf
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
be274a18cb8508ec24ce528e73b96166
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)
repository.mail.fl_str_mv bu@ufc.br || repositorio@ufc.br
_version_ 1847793404514140160